The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
Open accessAbstract
Objective: We aimed to provide an evidence-supported update of the ECCO-ESPGHAN guideline on the medical management of paediatric Crohn’s disease [CD]. Methods: We formed 10 working groups and formulated 17 PICO-structured clinical questions [Patients, Intervention, Comparator, and Outcome]. A systematic literature search from January 1, 1991 to March 19, 2019 was conducted by a medical librarian using MEDLINE, EMBASE, and Cochrane Central databases. A shortlist of 30 provisional statements were further refined during a consensus meeting in Barcelona in October 2019 and subjected to a vote. In total 22 statements reached ≥ 80% agreement and were retained. Results: We established that it was key to identify patients at high risk of a complicated disease course at the earliest opportunity, to reduce bowel damage. Patients with perianal disease, stricturing or penetrating behaviour, or severe growth retardation should be considered for up-front anti-tumour necrosis factor [TNF] agents in combination with an immunomodulator. Therapeutic drug monitoring to guide treatment changes is recommended over empirically escalating anti-TNF dose or switching therapies. Patients with low-risk luminal CD should be induced with exclusive enteral nutrition [EEN], or with corticosteroids when EEN is not an option, and require immunomodulator-based maintenance therapy. Favourable outcomes rely on close monitoring of treatment response, with timely adjustments in therapy when treatment targets are not met. Serial faecal calprotectin measurements or small bowel imaging [ultrasound or magnetic resonance enterography] are more reliable markers of treatment response than clinical scores alone. Conclusions: We present state-of-the-art guidance on the medical treatment and long-term management of children and adolescents with CD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–213 of 213
Kim, H. J., Kim, Y., Cho, J. M., Oh, S. H., & Kim, K. M. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.5.1185 · Cited by 25
Anti-tuberculous therapy for maintenance of remission in Crohn's disease
Patton, P. H., Parker, C. E., MacDonald, J. K., & Chande, N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000299.pub3 · Cited by 25
Gerich, M. E., Quiros, J. A., Marcin, J. P., Tennyson, L., Henthorn, M., & Prindiville, T. P. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.03.004 · Cited by 24
Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.
Boyle, B. M., Kappelman, M. D., Colletti, R. B., Baldassano, R. N., Milov, D. E., & Crandall, W. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.9185 · Cited by 23
Minderhoud, I. M., Steyerberg, E. W., Bodegraven, A. A. V., van der Woude, C. J., Hommes, D. W., Dijkstra, G. D. H., Fidder, H. H., Schwartz, M. P., & Oldenburg, B. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000507 · Cited by 23
Krishnakumar, C., Ballengee, C. R., Liu, C., Kim, M., Baker, S. S., Baldassano, R. N., Cohen, S. A., Crandall, W., Denson, L. A., Dubinsky, M. C., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy363 · Cited by 23
Self-citationSidoroff, M., & Kolho, K. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-51 · Cited by 22
Self-citationPerioperative Corticosteroid Management for Patients with Inflammatory Bowel Disease
Hicks, C. W., Wick, E. C., Salvatori, R., & Ha, C. Y. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000185 · Cited by 20
Fernandes, M. A., Verstraete, S. G., Garnett, E. A., & Heyman, M. B. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000967 · Cited by 18
Selinger, C. P., Lenti, M. V., Clark, T., Rafferty, H., Gracie, D. J., Ford, A. C., O’Connor, A., Ahmad, T., & Hamlin, P. J. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001258 · Cited by 18
Methotrexate for the Management of Crohn’s Disease in Children
Scherkenbach, L. A., & Stumpf, J. L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015613527 · Cited by 17
Hojsak, I., Mišak, Z., Jadrešin, O., Pavić, A. M., & Kolaček, S. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1031166 · Cited by 11
Paediatric magnetic resonance enteroclysis under general anaesthesia – initial experience
Sadigh, S., Chopra, M., Sury, M. R. J., Shah, N., Olsen, Ø. E., & Watson, T. A. (2017) · Pediatric Radiology · doi:10.1007/s00247-017-3836-7 · Cited by 10
Cited by
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Gordon, H., Minozzi, S., Kopylov, U., Verstockt, B., Chaparro, M., Buskens, C., Warusavitarne, J., Agrawal, M., Allocca, M., Atreya, R., et al. (2024) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjae091 · Cited by 388
ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Bager, P., Escher, J., Forbes, A., Hébuterne, X., Hvas, C. L., Joly, F., Klek, S., Krznaric, Z., Ockenga, J., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2022.12.004 · Cited by 367
Self-citationValdés-Mas, R., Leshem, A., Zheng, D., Cohen, Y., Kern, L., Zmora, N., He, Y., Katina, C., Eliyahu-Miller, S., Yosef-Hevroni, T., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.016 · Cited by 89
Self-citationGatti, S., Gelzoni, G., Catassi, G. N., & Catassi, C. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.742830 · Cited by 14
Giachero, F., Jenke, A., & Zilbauer, M. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1945442 · Cited by 7
“we recommend reading the most recent ECCO-ESPGHAN guideline update [50].”
BackgroundMethodInfluential
Metadata
- Authors
- van Rheenen, P. F., Aloi, M., Assa, A., Bronsky, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A., Henderson, P., Koletzko, S., Kolho, K.-L., Levine, A., van Limbergen, J., Martin de Carpi, F. J., Navas-López, V. M., Oliva, S., de Ridder, L., Russell, R. K., Shouval, D., Spinelli, A., Turner, D., Wilson, D., Wine, E., & Ruemmele, F. M.
- Venue
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-07
- Volume
- 15
- Issue
- 2
- Pages
- 171-194
- ISSN
- 1873-9946 (ISSN-L)
- 1876-4479
- OpenAlex
- W3092023159
- Cited by
- 729
- References
- 213
- FWCI
- 44.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.